RBC Capital analyst Ashish Sabadra maintained a Buy rating on MSCI (MSCI – Research Report) yesterday and set a price target of $675.00. The ...

In a report released yesterday, Irene Nattel from RBC Capital reiterated a Buy rating on SAP AG (SAP – Research Report), with a price target of ...

The firm acknowledges that Sunoco faces downside risks, which could stem from a negative shift in commodity market conditions or the economics of potential future projects and mergers and acquisitions ...

RBC Capital Markets advised on a total of 34 deals ... Evercore was third with 19, Barclays came fourth with 18 and Goldman Sachs secured fifth spot with 16 deals. GlobalData’s league tables ...

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...

But investors can still look forward to "solid" if more "moderate" returns in the year ahead, says RBC Capital Markets – and perhaps even better with the right stock investments. "The overall ...

"Prices have moved up nearly 16% since Thursday with no 'normal' reasons that could justify this price action," Tyler Broda, an RBC Capital Markets analyst, said in a February 1 research note.

On Thursday, RBC Capital Markets adjusted their stance on Neumora Therapeutics (NASDAQ:NMRA), downgrading the stock from an Outperform to a Sector Perform rating. This change comes in the wake of ...